01 Jun NIH recommends precision medicine approach to treat Alzheimer’s
NIH gathered healthcare experts to discuss how to best accelerate Alzheimer’s treatment with precision medicine, big data analytics and stakeholder collaboration
By Jessica Kent, Precision Medicine News
Precision medicine, big data analytics, and stakeholder collaboration could improve treatment and prevention of Alzheimer’s disease and related dementias, according to recommendations from the National Institutes of Health (NIH).
The recommendations were the result of the Alzheimer’s Disease Research Summit 2018: Path to Treatment and Prevention, convened by the National Institute on Aging (NIA), part of NIH.
More than 80 leading experts from government, academia, industry, and non-profit organizations gathered to guide continued efforts to build a collaborative, multi-stakeholder research environment capable of delivering urgently needed cures for people at all stages of Alzheimer’s.